Increased bone resorption is associated with increased risk of cardiovascular events in men: The MINOS study

Journal of Bone and Mineral Research

Volumn 24, Issue 12, 2009, Pages 2023-2031

  Szulc, Pawel ^a   Samelson, Elizabeth J ^b   Kiel, Douglas P ^b   Delmas, Pierre D ^a  

^a UNIVERSITÉ DE LYON   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BMD; Bone resorption; Cardiovascular disease; Cohort study; Men; Osteoporosis

Indexed keywords

BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE;

ADULT; AGED; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE TURNOVER; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPOROSIS; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; SELF REPORT; SMOKING; SPINE; STROKE;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; BONE RESORPTION; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; RISK FACTORS; STROKE;

EID: 73649145246     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090531     Document Type: Article

References (62)

1. Ezzati M, Henley J, Thun MJ, Lopez AD 2005 Role of smoking in global and regional cardiovascular mortality. Circulation 112:489-497.
2. Doll R, Peto R, Wheatley K, Gray R, Sutherland I 1994 Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309:901-911.
3. Szulc P, Garnero P, Claustrat B, Marchand F, Duboeuf F, Delmas PD 2002 Increased bone resorption in moderate smokers with low body weight: The Minos study. J Clin Endocrinol Metab 87:666-674.
4. Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES 2006 Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 91:3908-3915.
5. Kaufman JM, Vermeulen A 2005 The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833-876.
6. Szulc P, Claustrat B, Marchand F, Delmas PD 2003 Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: The MINOS study. J Clin Endocrinol Metab 88:5240-5247.
7. Hak AE, Witteman JCM, de Jong FH, Geerlings MI, Hofman A, Pols HAP 2002 Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study. J Clin Endocrinol Metab 87:2632-2639.
8. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G 2008 Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: A longitudinal study. J Clin Endocrinol Metab 93:1952-1958.
9. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V 2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397.
10. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH 2000 Plasma concentrations of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772.
11. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V 2004 Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246-4253.
12. Samelson EJ, Kiel DP, Broe KE, Zhang Y, Cupples LA, Hannan MT, Wilson PWF, Levy D, Williams SA, Vaccarino V 2004 Metacarpal cortical area and risk of coronary heart disease. The Framingham Study. Am J Epidemiol 159:589-595.
13. Tankó LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR 2005 Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20:1912-1920.
14. Farhat GN, Strotmeyer ES, Newman AB, Dutton-Tyrrell K, Bauer DC, Harris T, Johnson KC, Taaffe DR, Cauley JA 2006 Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: The Health, Aging, and Body Composition Study. Calcif Tissue Int 79:102-111.
15. Mussolino ME, Madans JH, Gillum RF 2003 Bone mineral density and stroke. Stroke 34:e20-e22.
16. Szulc P, Kiel D, Delmas PD 2008 Calcifications in the abdominal aorta predict fractures in men - MINOS study. J Bone Miner Res 23:95-102.
17. Samelson EJ, Cupples LA, Broe KE, Hannan MT, O'Donnell CJ, Kiel DP 2007 Vascular calcification in middle-age and long term risk of hip fracture: The Framingham study. J Bone Miner Res 22:1449-1454.
18. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PWF 2001 Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham Heart Study. Calcif Tissue Int 68:271-276.
19. Magnus JH, Broussard DL 2005 Relationship between bone mineral density and myocardial infarction in US adults. Osteoporos Int 16:2053-2062.
20. Sinnott B, Syed I, Sevrukov A, Barengolts E 2006 Coronary calcifications and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif Tissue Int 78:195-202.
21. Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, Mazières B 1994 Comparison of the bone mineral content of the lower limbs in men with ischemic atherosclerotic disease. Clin Rheumatol 13:611-614.
22. Wong SYS, Kwok T, Woo J, Lynn H, Griffith JF, Leung J, Tang YYN, Leung PC 2005 Bone mineral density and the risk of peripheral arterial disease in men and women: Results from Mr. and Ms Os, Hong Kong. Osteoporos Int 16:1933-1938.
23. van der Klift M, Pols HAP, Hak AE, Witteman JCM, Hofman A, de Laet CEDH 2002 Bone mineral density and the risk of peripheral arterial disease: The Rotterdam study. Calcif Tissue Int 70:443-449.
24. Mussolino ME, Gillum RF, Madans JH 2001 Bone mineral density and stroke risk. Stroke 32:2956-2957.
25. Jørgensen L, Engstad T, Jacobsen BK 2001 Bone mineral density in acute stroke patients. Low bone mineral density may predict first stroke in women. Stroke 32:47-51.
26. Szulc P, Marchand F, Duboeuf F, Delmas PD 2000 Cross-sectional assessment of age-related bone loss in men. Bone 26:123-129.
27. Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD 2001 Cross-sectional evaluation of bone metabolism in men. J Bone Miner Res 16:1642-1650.
28. Szulc P, Munoz F, Marchand F, Chapuy MC, Delmas PD 2003 Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: The MINOS study. Calcif Tissue Int 73:520-530.
29. Szulc P, Delmas PD 2008 Biochemical markers of bone turnover: Potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int 19:1683-1704.
30. Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F, Duboeuf F, Delmas PD 2001 Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study. J Clin Endocrinol Metab 86:192-199.
31. Abbott RD, Launer LJ, Rodriguez BL, Ross GW, Wilson PW, Masaki KH, Strozyk D, Curb JD, Yano K, Popper JS, Petrovich H 2007 Serum estradiol and risk of stroke in elderly men. Neurology 68:563-568.
32. Tivesten A, Hulthe J, Wallenfeldt K, Wikstrand J, Ohlsson C, Fagenberg B 2006 Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. J Clin Endocrinol Metab 91:4433-4437.
33. Ärnlöv J, Pencina MJ, Amin S, Nam BH, Benjamin EJ, Murabito JM, Wang TJ, Knapp PE, D'Agostino RB, Bhasin S, Vasan RS 2006 Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med 147:176-184.
34. Barrett-Connor E, Khaw KT 1988 Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 78:539-545.
35. Dawson-Hughes B 2008 Calcium and vitamin D. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th ed. American Society for Bone and Mineral Research, Washington, DC, USA, pp. 257-259.
36. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS 2008 Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503-511.
37. Giovanucci E, Liu Y, Hollis BW, Rimm EB 2008 25-hydroxyvitamin D and risk of myocardial infarction in men. A prospective study. Arch Intern Med 168:1174-1180.
38. Hofbauer LC, Schoppet M 2004 Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292:490-495.
39. Oh KW, Rhee EJ, Lee WY, Kim SW, Baek KH, Kang MI, Yun EJ, Park CY, Ihm SH, Choi MG, Yoo HJ, Park SW 2005 Circulating osteoprotegerin and rceptor activator of NF-κB ligand system are associated with bone metabolism in middle-aged males. Clin Endocrinol (Oxf) 62:92-98.
40. Khosla S, Arrighi HM, Melton LJ III, Atkinsn EJ, O'Fallon WM, Dunstan C, Riggs BL 2002 Correlates of osteoprotegerin levels in women and men. Osteoporos Int 13:394-399.
41. Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD 2001 Osteoprotegerin serum levels in men: Correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 86:3162-3165.
42. Samelson EJ, Broe KE, Demissie S, Beck TJ, Karasik D, Kathiresan S, Kiel DP 2008 Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip. J Clin Endocrinol Metab 93:1789-1795.
43. Price PA, June HH, Buckley JR, Williamson MK 2001 Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21:1616.
44. Schoppet M, Sattler AM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC 2003 Increased osteoprotegerin serum levels in men with coronary heart disease. J Clin Endocrinol Metab 88:1024-1028.
45. Kiechl S, Schett G, Schwaiger J, Seppi K, Eder P, Egger G, Santer P, Mayr A, Xu Q, Willeit J 2007 Soluble receptor activator of nuclear factor-κB ligand and risk for cardiovascular disease. Circulation 116:385-391.
46. Bruunsgaard H 2006 The clinical impact of systemic low-level inflammation in elderly populations. Dan Med Bull 53:285-309.
47. Kim BJ, Yu YM, Kim EN, Chung YE, Koh JM, Kim GS 2007 Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf) 67:152-158.
48. Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, Kuller LH, Cushman M 2007 Association of carotid artery intime-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality. The Cardiovascular Health Study. Circulation 116:32-38.
49. Simionescu A, Simionescu DT, Vyavahare NR 2007 Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-β1. Am J Pathol 171:116-123.
50. Bouvet C, Moreau S, Blanchette J, de Blois D, Moreau P 2008 Sequential activation of matrix metalloproteinase 9 and transforming growth factor β in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol 28:856-862.
51. Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR 2004 Elastin degradation and calcification in an abdominal aorta injury model. Role of matrix metalloproteinases. Circulation 110:3480-3487.
52. Qin X, Corriere MA, Matrisian LM, Guzman RJ 2006 Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol 26:1510-1516.
53. Walter MF, Jacob JF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, Masson MP 2004 Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: A longitudinal analysis of the PREVENT study. J Am Coll Cardiol 44:1996-2002.
54. Nicholls SJ, Hazen SL 2005 Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25:1102-1111.
55. Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O'Brien CA, Bellido T, Parfitt MA, Weinstein RS, Jilka RL, Manolagas SC 2007 Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282:27285-27297.
56. Almeida M, Han L, Martin-Millan M, O'Brien CA, Manolagas SC 2007 Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting β-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 282:27298-27305.
57. Nabeshima Y, Imura H 2008 a-Klotho: A regulator that integrates calcium homeostasis. Am J Nephrol 28:455-464.
58. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G 1997 Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81.
59. 2-Heremans-Schmid glycoprotein/ fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest2003112:357-366.
60. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EFM 2007 Systemic effects of smoking. Chest 131:1557-1566.
61. Fraser JD, Otawara Y, Price PA 1988 1,25-dihydroxyvitamin D3 stimulates the synthesis of matrix γ-carboxyglutamic acid protein by osteosarcoma cells. J Biol Chem 263:911-916.
62. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G 1997 Spontaneous calcification of arteries and cartilage inmice lacking matrix GLA protein. Nature 386:78-81.